contents area
Press Release
detail content area
- Date2020-10-03 22:00
- Update2020-10-03 22:14
- DivisionDirector for International Affairs
- Tel043-719-7753
- 88
□ As of 0:00, 03 October 2020, the total number of confirmed cases is 24,027 (including 3,270 imported cases), of which 21,787 cases have been discharged from isolation. There are 52 new local cases, 23 new imported cases, and 4 new deaths.
|
Local transmission cases, as of 0:00, 03 October (cumulative since 3 January 2020) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Imported cases, as of 0:00, 03 October (cumulative since 3 January 2020) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
※ Asia excluding China: Uzbekistan 5, Philippines 4, Indonesia 1, Russia 1, India 1 / Europe: Ukraine 3, Hungary 2 / Americas : US 3 / Africa : Egypt 1, Sudan 1, Liberia 1 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Case status, as of 0:00, 03 October (cumulative since 3 January 2020) |
||||||||||||||||||||
|
||||||||||||||||||||
|
* Based on case data reported to the KDCA |
|
Overall case and test status, as of 0:00, 03 October (cumulative since 3 January 2020) |
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
* Based on case data reported to the KDCA ** Testing in progress includes number of completed tests with negative results that are being recorded with delays ※ Figures subject to correction based on findings from epidemiological investigations |
||||||||||||||||||||||||||||||||||||||||||||
|
Regional distribution of cases, as of 0:00, 03 October (cumulative since 3 January 2020) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Total (cumulative) number of cases reported since January 2020 of region / Population of region (based on resident registration data of the Ministry of the Interior as of January 2020) * Incidence rate based on the number of confirmed cases with the address of the reporting institution |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Major local clusters as of 12:00 today (03 October 2020) |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
* The specific figures may differ from the daily reported statistics or figures disclosed by local municipalities due to factors such as report timing and differences in the time period considered |
□ KDCA distributed Remdesivir to 529 patients in 60 hospitals
□ KDCA asked the public to "stay home" during the Chuseok holidays and avoid traveling
□ KDCA also reminded the public to hold non-face to face methods of all religious activities
|
REGIONAL DISTRIBUTION AND EPIDEMIOLOGICAL LINKS OF CONFIRMED CASES |
||||||||||
|
Region |
Confirmed cases |
Other major clusters |
||||||||
|
Total |
Imported cases |
Clusters |
Other* |
Under investigation |
New cases |
|||||
|
Sub- |
Shin- |
Other local clusters |
Related to imported cases |
|||||||
|
total |
cheonji cluster |
|||||||||
|
Seoul |
5,360 |
416 |
2,979 |
8 |
2,898 |
73 |
1,008 |
957 |
26 |
Past large clusters: • Sarang Jeil Church (1,174) • Aug 15 Seoul rallies (646) • Nightclubs (277) • Richway (210) • Guro-gu call center (170) • Coupang fulfillment center (152) • Gwangju door-to-door sales (150) • Fitness/sport facility in Cheonan (123) • Newly planted churches group (119) Recent clusters: • Severance Hospita • Dana clinic • Health Products Business Seminar • Pyunggang clinic • Daeji/Jukjeon Highschool • Sonmang Church • Daewoo Deoville plus • Bakaewon (mental health care facility) • Yemaru Day Care Center • Sammosporex Sauna • Day care center in Icheon • Elderly gathering in Pohang • Defense industry company in Sungnam • DongA University Bumin campus |
|
Busan |
453 |
51 |
292 |
12 |
225 |
55 |
55 |
55 |
8 |
|
|
Daegu |
7,133 |
81 |
5,369 |
4,512 |
853 |
4 |
934 |
749 |
0 |
|
|
Incheon |
930 |
99 |
618 |
2 |
608 |
8 |
115 |
98 |
7 |
|
|
Gwangju |
495 |
55 |
377 |
9 |
362 |
6 |
34 |
29 |
0 |
|
|
Daejeon |
362 |
34 |
198 |
2 |
196 |
0 |
87 |
43 |
2 |
|
|
Ulsan |
147 |
36 |
77 |
16 |
57 |
4 |
22 |
12 |
0 |
|
|
Sejong |
76 |
15 |
47 |
1 |
45 |
1 |
10 |
4 |
0 |
|
|
Gyeonggi |
4,434 |
591 |
2,552 |
29 |
2,457 |
66 |
730 |
561 |
10 |
|
|
Gangwon |
224 |
26 |
132 |
17 |
114 |
1 |
39 |
27 |
0 |
|
|
Chung-buk |
173 |
33 |
88 |
6 |
75 |
7 |
28 |
24 |
1 |
|
|
Chung-nam |
489 |
65 |
296 |
0 |
295 |
1 |
76 |
52 |
1 |
|
|
Jeonbuk |
129 |
40 |
52 |
1 |
51 |
0 |
23 |
14 |
1 |
|
|
Jeonnam |
173 |
39 |
104 |
1 |
101 |
2 |
22 |
8 |
3 |
|
|
Gyeong-buk |
1,562 |
57 |
1,160 |
566 |
594 |
0 |
202 |
143 |
2 |
|
|
Gyeong-nam |
291 |
75 |
172 |
32 |
137 |
3 |
21 |
23 |
0 |
|
|
Jeju |
59 |
20 |
11 |
0 |
10 |
1 |
22 |
6 |
0 |
|
|
Ports of Entry |
1,537 |
1,537 |
0 |
0 |
0 |
0 |
0 |
0 |
14 |
|
|
Total |
24,027 |
3,270 |
14,467 |
5,214 |
9,021 |
232 |
3,401 |
2,784 |
75 |
|
|
(%) |
-13.6 |
-60.2 |
-21.7 |
-37.5 |
-1 |
-14.2 |
-11.6 |
|||
| * Includes contacts of confirmed cases ※ The interim classification is based on the reporting location, which may change depending on further epidemiological investigation. |
||||||||||
|
AGE DISTRIBUTION OF SEVERE CASES |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Total |
Severe |
( |
% |
) |
Critical |
( |
% |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Total |
104 |
52 |
( |
100.0 |
) |
52 |
( |
100.0 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
80 and above |
19 |
11 |
( |
21.2 |
) |
8 |
( |
15.4 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
70-79 |
39 |
17 |
( |
32.7 |
) |
22 |
( |
42.3 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
60-69 |
34 |
18 |
( |
34.6 |
) |
16 |
( |
30.8 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
50-59 |
7 |
3 |
( |
5.8 |
) |
4 |
( |
7.7 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
40-49 |
3 |
1 |
( |
1.9 |
) |
2 |
( |
3.8 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
30-39 |
1 |
1 |
( |
1.9 |
) |
0 |
( |
0.0 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
20-29 |
1 |
1 |
( |
1.9 |
) |
0 |
( |
0.0 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
10-19 |
0 |
0 |
( |
0.0 |
) |
0 |
( |
0.0 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
0-9 |
0 |
0 |
( |
0.0 |
) |
0 |
( |
0.0 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Critical: patients treated with mechanical ventilator, ECMO (Extracorporeal Membrane Oxygenation), CRRT (Continuous Renal Replacement Therapy)
* Severe: patients treated with oxygen mask and high flow oxygen therapy
* ICU treatment is decided based on the need for intensive care based on factors such as clinical condition and presence of any underlying medical condition and may differ from severe and critical case classification criteria. The number of severe/critical cases may not match the number of patients in ICU.
|
Confirmed cases by gender and age group |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Total (cumulative) number of cases reported since January 2020 by sex and age / Population by sex and age (based on resident registration data of the Ministry of the Interior as of January 2020)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Deaths by gender and age group |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
IMPORTED CASES |
|
NEW CASES (LAST 2 WEEKS) BY CHAIN OF TRANSMISSION |
This public work may be used under the terms of the public interest source + commercial use prohibition + nonrepudiation conditions